AI-assisted colonoscopy for polyp detection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of an artificial intelligence system in improving the detection rates of adenomas during colonoscopy. It compares polyp detection and adenoma detection rates in multiple centers using AI-assisted colonoscopy versus traditional methods. The study is observational and aims to gather real-world data on the performance of AI in enhancing colonoscopy quality control and polyp detection. Participants will undergo diagnostic, screening, or follow-up colonoscopy as part of the study.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. age \> 50 years old;
2. required diagnostic colonoscopy, screening colonoscopy, or follow-up colonoscopy;
3. voluntarily sign informed consent;
4. Commitment to abide by the study procedures and cooperate with the implementation of the whole process of the study.

Exclusion Criteria:

1. have participated in other clinical trials, signed informed consent and are in the follow-up period of other clinical trials;
2. known polyposis syndrome patients;
3. patients with known IBD;
4. patients considered by the investigators to be unsuitable or unable to undergo complete digestive endoscopy and related examinations;
5. high-risk diseases or other special conditions considered by the investigator to be unsuitable for clinical trial participation.

Where it's running

• Renmin Hospital of Wuhan Univercity
  Wuhan, Hubei, China Recruiting

Study contacts

• Study coordinator: Honggang Yu, Doctor
• Email: wjlnsm@163.com
• Phone: 18771146096

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• GelPOINT Path-assisted endoscopic removal of colorectal polyps

  This study tests whether using the GelPOINT Path access platform during endoscopic submucosal dissection can safely help remove colorectal polyps in adults.

  Recruiting Baylor College of Medicine · Houston, Texas · NCT07723937

• Liquid biopsy and machine learning to detect early colorectal cancer, advanced adenomas, Lynch-related cancers, and residual disease

  This project will test a blood-based liquid biopsy that uses microRNA signals and machine learning to detect colorectal cancer, advanced adenomas, Lynch-associated cancers, and molecular residual disease in people who have a colonoscopy.

  Recruiting San Raffaele University · Milan, Lombardy and 3 other locations · NCT07450612

• Bi‑manual EndoTEM system to remove polyps from the rectum and lower sigmoid colon

  This will test whether the EndoTEM system can safely and completely remove large rectal and distal sigmoid polyps in adults.

  Recruiting Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) · Freiburg im Breisgau and 2 other locations · NCT07146165

• Using deep learning and Raman spectroscopy for early cancer diagnosis

  This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.

  Recruiting at 4 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Nanchang, Jiangxi and 3 other locations · NCT06822413

• Testing rectal mucus for colorectal cancer detection

  This study is testing a new way to use rectal mucus samples to see if it can help find colorectal cancer and important polyps in patients who need urgent cancer checks.

  Recruiting Origin Sciences · Telford, Shropshire · NCT06649123

• Evaluating adenoma recurrence after specific endoscopic procedures

  This study is testing which of two different techniques for removing large colon polyps helps prevent the return of adenomas in adults who are having a colonoscopy.

  Recruiting AdventHealth · Orlando, Florida · NCT06476145

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.